FDA approves LimFlow to reduce amputations after UH studies

The research found that the therapy enabled most patients treated to keep their leg and experience wound healing.

Related Keywords

United States , Americans , Mehdi Shishehbor , Cindy Elford , James Hambrick , Drug Administration , University Hospitals Cleveland Medical Center , University Hospitals Uh Harrington Heart Vascular Institute , University Hospitals , Uh Harrington Heart Vascular Institute , New England Journal , Multicenter Prospective Study , Harrington Heart , Vascular Institute , African Americans , Jaqueline Early , James Hambrick Chair ,